|
Group
|
Number of high-risk cases
|
Accepted invasive testing
|
Declined invasive testing
|
Number of confirmed cases
|
Terminate pregnancy
|
Continue pregnancy
|
|---|
|
Common aneuploidies
|
267
|
221(82.77%)
|
46(17.23%)
|
177
|
177(100%)
|
0(0%)
|
|
T21
|
178
|
153(85.96%)
|
25(14.04%)
|
139
|
139(100%)
|
0(0%)
|
|
T18
|
51
|
37(72.55%)
|
14(27.45%)
|
29
|
29(100%)
|
0(0%)
|
|
T13
|
38
|
31(81.58%)
|
7(18.42%)
|
9
|
9(100%)
|
0(0%)
|
|
Fetal SCAs
|
179***
|
118(65.92%)
|
61(34.08%)
|
24***
|
5(20.83%)
|
19(79.17%)
|
|
45,X
|
82***
|
51(62.2%)
|
31(37.8%)
|
5***
|
1(20%)
|
4(80%)
|
|
47,XXX
|
25***
|
12(48%)
|
13(52%)
|
13
|
NA
|
NA
|
|
47,XXY
|
48
|
34(70.83%)
|
14(29.17%)
|
12***
|
2(16.67%)
|
10(83.33%)
|
|
47,XYY
|
24
|
21(87.5%)
|
3(12.5%)
|
7***
|
2(28.57%)
|
5(71.43%)
|
|
RATs
|
54***
|
33(61.11%)
|
21(38.89%)
|
3
|
NA
|
NA
|
|
CNVs
|
33***
|
16(48.48%)
|
17(51.52%)
|
8***
|
6(75%)
|
2(25%)
|
|
CNVs (< 10 M)
|
12*
|
7(58.33%)
|
5(41.67%)
|
3***
|
1(33.33%)
|
2(66.67%)
|
|
CNVs(> 10 M)
|
21***
|
9(42.86%)
|
12(57.14%)
|
5
|
5(100%)
|
0
|
- *< 0.05, ***< 0.005, Fisher’s exact test. The differences in the rate of prenatal diagnosis and termination of pregnancy were compared between the common aneuploidies group and any other group
